verapamil has been researched along with Kidney Stones in 8 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We evaluated postoperative outcome of patients subjected to standard ANL that received 10 mg of Verapamil immediately before declamping renal artery, due to prevention of reperfusion injury." | 7.74 | Using verapamil as protective factor in renal ischemia reperfusion injury during anatrophic nephrolithotomy. ( Aganović, D; Hadziosmanović, O; Kulovac, B; Prcić, A, 2007) |
| " We evaluated postoperative outcome of patients subjected to standard ANL that received 10 mg of Verapamil immediately before declamping renal artery, due to prevention of reperfusion injury." | 3.74 | Using verapamil as protective factor in renal ischemia reperfusion injury during anatrophic nephrolithotomy. ( Aganović, D; Hadziosmanović, O; Kulovac, B; Prcić, A, 2007) |
| "The overall stone recurrence rate was 14% (10/70)." | 2.72 | The effect of calcium channel blockers on stone regrowth and recurrence after shock wave lithotripsy. ( Erturhan, S; Inal, Y; Sarica, K; Yağci, F, 2006) |
| "Verapamil has been found to be protective against crystal deposition." | 1.30 | Limitation of shockwave-induced enhanced crystal deposition in traumatized tissue by verapamil in rabbit model. ( Akbay, C; Bakir, K; Korkmaz, C; Sarica, K; Sayin, N; Topçu, O; Yağci, F, 1999) |
| "Verapamil was found to significantly reduce the urinary oxalate excretion of the 5 hyperoxaluric (> or = 50 mg/day) patients but no significant effect on urinary calcium, magnesium or citric acid was observed." | 1.29 | [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers]. ( Iguchi, M; Ikegami, M; Ishikawa, Y; Kiwamoto, H; Kohri, K; Kurita, T; Umekawa, T, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sarica, K | 2 |
| Inal, Y | 1 |
| Erturhan, S | 1 |
| Yağci, F | 2 |
| Aganović, D | 1 |
| Kulovac, B | 1 |
| Prcić, A | 1 |
| Hadziosmanović, O | 1 |
| Strohmaier, WL | 1 |
| Bichler, KH | 1 |
| Koch, J | 1 |
| Balk, N | 1 |
| Wilbert, DM | 1 |
| Iguchi, M | 1 |
| Ikegami, M | 1 |
| Kiwamoto, H | 1 |
| Umekawa, T | 1 |
| Ishikawa, Y | 1 |
| Kohri, K | 1 |
| Kurita, T | 1 |
| Bakir, K | 1 |
| Topçu, O | 1 |
| Akbay, C | 1 |
| Sayin, N | 1 |
| Korkmaz, C | 1 |
| Halabe, A | 1 |
| Wong, NL | 1 |
| Sutton, RA | 1 |
| Karaev, ME | 1 |
| Samedov, RN | 1 |
| Vezirov, MS | 1 |
| Kaliaev, ShM | 1 |
| Walts, LF | 1 |
| Atlee, JL | 1 |
2 trials available for verapamil and Kidney Stones
| Article | Year |
|---|---|
The effect of calcium channel blockers on stone regrowth and recurrence after shock wave lithotripsy.
Topics: Adolescent; Adult; Calcium Channel Blockers; Drinking; Female; Humans; Kidney Calculi; Lithotripsy; | 2006 |
Protective effect of verapamil on shock wave induced renal tubular dysfunction.
Topics: Acetylglucosaminidase; Alpha-Globulins; Humans; Kidney Calculi; Kidney Tubules; Lithotripsy; Mucopro | 1993 |
6 other studies available for verapamil and Kidney Stones
| Article | Year |
|---|---|
Using verapamil as protective factor in renal ischemia reperfusion injury during anatrophic nephrolithotomy.
Topics: Adult; Female; Humans; Kidney; Kidney Calculi; Male; Middle Aged; Nephrostomy, Percutaneous; Renal A | 2007 |
[Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
Topics: Calcium; Citrates; Citric Acid; Female; Humans; Kidney Calculi; Magnesium; Male; Middle Aged; Oxalat | 1993 |
Limitation of shockwave-induced enhanced crystal deposition in traumatized tissue by verapamil in rabbit model.
Topics: Animals; Calcium Channel Blockers; Disease Models, Animal; Kidney; Kidney Calculi; Lithotripsy; Pros | 1999 |
The effect of verapamil and thiazide in the prevention of renal stone formation.
Topics: Animals; Calcium; Chlorothiazide; Ethylene Glycol; Ethylene Glycols; Hydroxycholecalciferols; Kidney | 1990 |
[Effect of preoperative administration of isoptin on the blood flow and function of the kidneys in patients with nephrolithiasis].
Topics: Adult; Humans; Kidney; Kidney Calculi; Kidney Tubules; Male; Middle Aged; Preoperative Care; Renal C | 1988 |
Supraventricular tachycardia associated with extracorporeal shock wave lithotripsy.
Topics: Aged; Electrocardiography; Female; Humans; Kidney Calculi; Lithotripsy; Middle Aged; Tachycardia, Su | 1986 |